Anna Barata is a research fellow at the Massachusetts General Hospital Cancer Center and Harvard Medical School. She graduated in Psychology (Universitat Ramón Llull, Barcelona), received a Master in Psycho-Oncology (Universidad Complutense de Madrid) and earned a PhD in Psychiatry and Medical Psychology (Universitat Autònoma de Barcelona). She completed a postdoctoral fellowship in behavioral oncology at the Moffitt Cancer Center (Tampa, FL).
Dr. Barata´s research focuses on improving survivorship in patients with hematological cancers and receiving treatment with hematopoietic cell transplant and adoptive cellular therapies. She is interested in examining patient-reported and neurocognitive outcomes, testing psychological and behavioral interventions to improve patients and informal caregivers’ quality of life, and developing relevant patient-reported outcomes measures. She currently serves as the principal investigator of an R03 successfully funded by the National Institutes of Health to examine patient-reported side effects of chimeric antigen receptor T-cell therapy.